US Patent Issued to OXFORD UNIVERSITY INNOVATION on June 9 for "Gene therapy for retinal disease" (British Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,007, issued on June 9, was assigned to OXFORD UNIVERSITY INNOVATION Ltd. (Oxford, Great Britain).

"Gene therapy for retinal disease" was invented by Harry O. Orlans (Oxford, Great Britain), Robert E. Maclaren (Oxford, Great Britain), Michelle E. McClements (Oxford, Great Britain) and Alun R Barnard (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a retinal disease in a subject in need thereof, the method comprising administering to the subject a vector that comprises a mirtron for knocking down expression of a target gene expressed in the retina and a gene therapy vector comprising a mirtron for rhodopsin kno...